Jonathan Mani

Radiation Oncology
800 NE 10th St
Oklahoma City, OK 73104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage.

Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage.

Journal: International journal of radiation biology
Published: February 14, 2020
Showing 1-1 of 1

Last Updated: 09/26/2026